Breast Cancer Drug may Offer Hope for Treating Ovarian Cancer

by VR Sreeraman on  June 15, 2007 at 4:02 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Breast Cancer Drug may Offer Hope for Treating Ovarian Cancer
Researchers from Edinburgh University have revealed that drug letrozole, which is used to treat breast cancer, can increase the life span of people suffering from Ovarian cancer by three years.

The researcher used the drug to stop oestrogen from stimulating tumour growth.

Though the discovery may not benefit all because not all cases of ovarian cancer, which is also called a 'silent killer' are triggered by oestrogen, it still offers hope to thousands, reports Daily Mail.

The study that involved 44 women found that the drug stopped oestrogen supply to tumours for almost half a year, in 25pct of the women.

In one-third of the women, whose tumours were largely dependent on oestrogen, the drug deferred chemotherapy.

The researchers expect the drug to increase life expectancy from sa number of months to almost three years.

Source: ANI
SRM /M

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Ovarian Cancer Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive